RARE Foundation Announces 2026 RARE Artist Awardees
Ten artists recognized across six categories will share their stories with national policymakers during Rare Disease Week on Capitol Hill in March 2027 WASHINGTON, Nov. 5, 2026 /PRNewswire/ -- The RARE Foundation, today announced the ten awardees of its 2026 RARE Artist program,...
Covered in this story
Analyst targets on Ultragenyx Pharmaceutical
- H.C. Wainwright: $25.6 → $50 by Aug 2027 · Buy via Investing.com
- Wells Fargo: $25.6 → $50 by Aug 2027 · Overweight via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $RARE yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Ultragenyx Pharmaceutical →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.